Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/130308
Campo DC Valoridioma
dc.contributor.authorMiró, Òscaren_US
dc.contributor.authorConde Martel, Aliciaen_US
dc.contributor.authorLlorens, Pereen_US
dc.contributor.authorSalamanca-Bautista, Pradoen_US
dc.contributor.authorGil, Víctoren_US
dc.contributor.authorGonzález-Franco, Álvaroen_US
dc.contributor.authorJacob, Javieren_US
dc.contributor.authorCasado, Jesúsen_US
dc.contributor.authorTost, Josepen_US
dc.contributor.authorMontero-Pérez-Barquero, Manuelen_US
dc.contributor.authorAlquézar-Arbé, Aitoren_US
dc.contributor.authorTrullàs, Joan Carlesen_US
dc.date.accessioned2024-05-13T08:57:43Z-
dc.date.available2024-05-13T08:57:43Z-
dc.date.issued2023en_US
dc.identifier.issn0953-6205en_US
dc.identifier.urihttp://hdl.handle.net/10553/130308-
dc.description.abstractObjective: The role of comorbidities in heart failure (HF) outcome has been previously investigated, although mostly individually. We investigated the individual effect of 13 comorbidities on HF prognosis and looked for differences according to left-ventricular ejection fraction (LVEF), classified as reduced (HFrEF), mildly-reduced (HFmrEF) and preserved (HFpEF). Methods: We included patients from the EAHFE and RICA registries and analysed the following comorbidities: hypertension, dyslipidaemia, diabetes mellitus (DM), atrial fibrillation (AF), coronary artery disease (CAD), chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), heart valve disease (HVD), cerebrovascular disease (CVD), neoplasia, peripheral artery disease (PAD), dementia and liver cirrhosis (LC). Association of each comorbidity with all-cause mortality was assessed by an adjusted Cox regression analysis that included the 13 comorbidities, age, sex, Barthel index, New York Heart Association functional class and LVEF and expressed as adjusted Hazard Ratios (HR) with 95% confidence intervals (95%CI). Results: We analysed 8,336 patients (82 years-old; 53% women; 66% with HFpEF). Mean follow-up was 1.0 years. Respect to HFrEF, mortality was lower in HFmrEF (HR:0.74;0.64-0.86) and HFpEF (HR:0.75;0.68-0.84). Considering patients all together, eight comorbidities were associated with mortality: LC (HR:1.85;1.42-2.42), HVD (HR:1.63;1.48-1.80), CKD (HR:1.39;1.28-1.52), PAD (HR:1.37;1.21-1.54), neoplasia (HR:1.29;1.15-1.44), DM (HR:1.26;1.15-1.37), dementia (HR:1.17;1.01-1.36) and COPD (HR:1.17;1.06-1.29). Associations were similar in the three LVEF subgroups, with LC, HVD, CKD and DM remaining significant in the three subgroups. Conclusion: HF comorbidities are associated differently with mortality, LC being the most associated with mortality. For some comorbidities, this association can be significantly different according to the LVEF.en_US
dc.languageengen_US
dc.relation.ispartofEuropean Journal of Internal Medicineen_US
dc.sourceEuropean Journal of Internal Medicine [ISSN 0953-6205], v.111, p. 97-104 (Mayo 2023)en_US
dc.subject320501 Cardiologíaen_US
dc.subject.otherComorbidityen_US
dc.subject.otherHeart failureen_US
dc.subject.otherInternal medicineen_US
dc.subject.otherLiver cirrhosisen_US
dc.subject.otherMortalityen_US
dc.titleThe influence of comorbidities on the prognosis after an acute heart failure decompensation and differences according to ejection fraction: Results from the EAHFE and RICA registriesen_US
dc.typeinfo:eu-repo/semantics/articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.ejim.2023.02.026en_US
dc.identifier.pmid36914535-
dc.identifier.scopus2-s2.0-85149862409-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid0000-0002-2540-3880-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid0000-0002-1753-6624-
dc.contributor.orcid0000-0003-3757-0579-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid0000-0003-1101-1066-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid0000-0003-3846-9616-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.contributor.orcid#NODATA#-
dc.description.lastpage104en_US
dc.description.firstpage97en_US
dc.relation.volume111en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.description.numberofpages7en_US
dc.utils.revisionen_US
dc.date.coverdateMayo, 2023en_US
dc.identifier.ulpgcNoen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr1,1
dc.description.jcr8,0
dc.description.sjrqQ1
dc.description.jcrqQ1
dc.description.scieSCIE
dc.description.miaricds11,0
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Patología y Tecnología médica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-2540-3880-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameConde Martel, Alicia-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

4
actualizado el 06-oct-2024

Citas de WEB OF SCIENCETM
Citations

3
actualizado el 06-oct-2024

Visitas

50
actualizado el 10-ago-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.